Literature DB >> 8877931

Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.

N Ishiguro1, T Ito, K Obata, N Fujimoto, H Iwata.   

Abstract

OBJECTIVE: To investigate the correlation between serum and synovial fluid (SF) concentrations of stromelysin-1 (MMP-3), gelatinases (MMP-2 and MMP-9), tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in patients with rheumatoid arthritis (RA) and to assess the role of these proteins in cartilage destruction and their clinical value as indicators of disease activity.
METHODS: Enzyme linked immunoassays (ELISA) were used. SF and serum samples were collected simultaneously from 55 patients with RA. Radiographic (Larsen grade) and clinical evaluations were also done.
RESULTS: There was significant correlation between SF concentrations of MMP-3 and MMP-9. In addition, there was significant negative correlation between SF concentrations of TIMP-2 and MMP-2, 3, and 9. The only correlation observed among MMP and TIMP in serum was that of MMP-3 with MMP-2. Significant correlation was also found between MMP-3 concentrations in the serum and SF. There were no significant correlations between radiological grade and concentrations of these proteins. Patients with mild to moderate functional disability showed significantly higher serum TIMP-1 concentrations than patients with severe disability.
CONCLUSION: Extremely high concentrations of MMP-3 in SF of the patients with RA may contribute to its elevation in serum. It would seem that regulation of TIMP production depends upon the disease state and not the concentration of MMP. Discrepancies between concentrations of TIMP and MMP in SF may be responsible for cartilage destruction in RA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877931

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

1.  Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?

Authors:  Salih Pay; Hakan Erdem; Aysel Pekel; Ismail Simsek; Ugur Musabak; Ali Sengul; Ayhan Dinc
Journal:  Rheumatol Int       Date:  2005-10-05       Impact factor: 2.631

2.  MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.

Authors:  I Tchetverikov; L S Lohmander; N Verzijl; T W J Huizinga; J M TeKoppele; R Hanemaaijer; J DeGroot
Journal:  Ann Rheum Dis       Date:  2005-05       Impact factor: 19.103

3.  Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.

Authors:  C Ribbens; M Martin y Porras; N Franchimont; M-J Kaiser; J-M Jaspar; P Damas; F A Houssiau; M G Malaise
Journal:  Ann Rheum Dis       Date:  2002-02       Impact factor: 19.103

4.  Alpinia galanga extracts downregulate interleukin-1β-induced matrix metalloproteinases expression in human synovial fibroblasts.

Authors:  Peraphan Pothacharoen; Kanyamas Choocheep; Thanyaluck Phitak; Wilart Pompimon; Prachya Kongtawelert
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-12-04       Impact factor: 2.416

5.  Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3.

Authors:  B Stix; T Kähne; K Sletten; J Raynes; A Roessner; C Röcken
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  Serum levels of tissue inhibitor of metalloproteinase-1 and periarticular bone loss in early rheumatoid arthritis.

Authors:  Eithne Murphy; Pascale Roux-Lombard; Terence Rooney; Oliver Fitzgerald; Jean-Michel Dayer; Barry Bresnihan
Journal:  Clin Rheumatol       Date:  2008-11-26       Impact factor: 2.980

7.  Concentrations of circulating matrix metalloproteinase 9 inversely correlate with autoimmune antibodies to double stranded DNA: implications for monitoring disease activity in systemic lupus erythematosus.

Authors:  G S Makowski; M L Ramsby
Journal:  Mol Pathol       Date:  2003-08

8.  Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model.

Authors:  Andrew D Rowan; Wang Hui; Tim E Cawston; Carl D Richards
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

9.  Serum pro-matrix metalloproteinase-3 as an indicator of disease activity and severity in rheumatoid arthritis: comparison with traditional markers.

Authors:  Aşkin Ateş; Nuran Türkçapar; Umit Olmez; Olcay Tiryaki; Nurşen Düzgün; Emre Uğuz; Murat Duman
Journal:  Rheumatol Int       Date:  2007-04-11       Impact factor: 3.580

10.  Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis.

Authors:  Sylvia Dörr; Nadine Lechtenböhmer; Rolf Rau; Gertraud Herborn; Ulf Wagner; Bertram Müller-Myhsok; Ingo Hansmann; Gernot Keyszer
Journal:  Arthritis Res Ther       Date:  2004-03-08       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.